Office of Technology Development

Technologies Available for Collaboration

Technologies Available for Collaboration


Neuroscience

Neurological disease modelingFred Gage
Details»
Animal models of neuronal loss in diseases such as Parkinson’sMartyn Goulding
Details»
Therapeutic compounds for neurodegenerative and metabolic diseasePamela Maher
Details»
Novel molecular targets for treating schizophreniaKuo-Fen Lee
Details»
Repair of synaptic connections following injuries such as strokeNicola Allen
Details»
Optogenetics in the treatment of Parkinson’s diseaseXin Jin
Details»
Imaging of specific neuronal cell types in awake, behaving animalsAxel Nimmerjhan
Details»
In vitro model of myelination and MSFred Gage
Details»
Compound for the treatment of ischemic strokeDavid Schubert
Details»

Oncology

A cell-based screen to identify therapeutic compounds for pancreatic cancerRonald Evans
Details»
SKIP and cancer therapyKatherine Jones
Details»
ULK1 Inhibitors, in combination with mTOR inhibitors as a cytotoxic cancer therapyReuben Shaw
Details»
Cancer models that replicate the characteristics of human diseaseInder Verma
Details»
New targets for triple negative breast cancer Geoff Wahl
Details»
Mouse models of non-small cell lung carcinomaReuben Shaw
Details»

Miscellaneous

Therapy for hemophiliaInder Verma
Details»
Increasing production of recombinant proteinsGeoff Wahl
Details»
High throughtput screen for modulators of protein-protein interactions (PPI)Geoff Wahl
Details»
Motor neuron dysfunction in ALS and spinal muscular atrophy (SMA)Sam Pfaff

Connect With Us